Saturna Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.5M Sell
311,008
-1,654
-0.5% -$254K 0.67% 33
2025
Q4
$43.1M Sell
312,662
-2,639
-0.8% -$346K 0.57% 35
2025
Q3
$40.4M Sell
315,301
-575
-0.2% -$70.2K 0.52% 37
2025
Q2
$38.2M Sell
315,876
-4,290
-1% -$484K 0.52% 43
2025
Q1
$35.7M Sell
320,166
-100
-0% -$10.6K 0.53% 47
2024
Q4
$31.2M Buy
320,266
+2,248
+0.7% +$240K 0.42% 52
2024
Q3
$36.6M Sell
318,018
-8,395
-3% -$953K 0.48% 51
2024
Q2
$34.7M Sell
326,413
-1,471
-0.4% -$148K 0.46% 50
2024
Q1
$31.7M Buy
327,884
+228
+0.1% +$23.4K 0.44% 55
2023
Q4
$33.1M Sell
327,656
-1,805
-0.5% -$174K 0.52% 53
2023
Q3
$33.6M Buy
329,461
+17,795
+6% +$1.81M 0.59% 52
2023
Q2
$31.5M Buy
311,666
+1,400
+0.5% +$140K 0.54% 55
2023
Q1
$28.5M Sell
310,266
-430
-0.1% -$37.6K 0.55% 56
2022
Q4
$28.2M Sell
310,696
-15,519
-5% -$1.31M 0.61% 52
2022
Q3
$24.8M Buy
326,215
+257
+0.1% +$21.3K 0.6% 53
2022
Q2
$27.6M Buy
325,958
+220
+0.1% +$19.3K 0.65% 53
2022
Q1
$28.6M Buy
325,738
+5,610
+2% +$486K 0.58% 53
2021
Q4
$28.7M Sell
320,128
-1,150
-0.4% -$95.5K 0.51% 52
2021
Q3
$26.3M Buy
321,278
+37,605
+13% +$3.38M 0.53% 55
2021
Q2
$25.9M Buy
283,673
+2,700
+1% +$240K 0.53% 55
2021
Q1
$24M Sell
280,973
-15,680
-5% -$1.41M 0.54% 54
2020
Q4
$28M Buy
296,653
+460
+0.2% +$40.2K 0.63% 55
2020
Q3
$25.8M Buy
296,193
+390
+0.1% +$33.8K 0.66% 53
2020
Q2
$25.8M Buy
295,803
+400
+0.1% +$34.5K 0.73% 51
2020
Q1
$25.9M Buy
295,403
+5,675
+2% +$506K 0.84% 51
2019
Q4
$27.4M Buy
289,728
+1,400
+0.5% +$126K 0.74% 53
2019
Q3
$25.1M Buy
288,328
+1,834
+0.6% +$165K 0.73% 53
2019
Q2
$26.2M Sell
286,494
-33,178
-10% -$2.81M 0.77% 52
2019
Q1
$27.5M Sell
319,672
-3,330
-1% -$267K 0.8% 54
2018
Q4
$24.8M Buy
323,002
+56
+0% +$4.36K 0.84% 55
2018
Q3
$24.9M Sell
322,946
-279
-0.1% -$20.6K 0.73% 56
2018
Q2
$21.9M Sell
323,225
-434,793
-57% -$30M 0.7% 60
2018
Q1
$54.9M Buy
758,018
+334
+0% +$25.4K 1.75% 18
2017
Q4
$57M Hold
757,684
1.74% 20
2017
Q3
$58.3M Sell
757,684
-6,779
-0.9% -$512K 1.89% 11
2017
Q2
$57.2M Sell
764,463
-279
-0% -$19.8K 1.9% 11
2017
Q1
$50.9M Buy
764,742
+1,070
+0.1% +$71.3K 1.73% 16
2016
Q4
$49.8M Sell
763,672
-307,123
-29% -$19.9M 1.75% 14
2016
Q3
$75.8M Sell
1,070,795
-111,712
-9% -$8.14M 2.47% 5
2016
Q2
$87.4M Sell
1,182,507
-502
-0% -$34.7K 2.8% 3
2016
Q1
$81.2M Sell
1,183,009
-22,320
-2% -$1.52M 2.6% 4
2015
Q4
$92.9M Sell
1,205,329
-237
-0% -$18.8K 2.87% 3
2015
Q3
$99.3M Hold
1,205,566
3.12% 3
2015
Q2
$106M Sell
1,205,566
-334
-0% -$30.6K 2.98% 2
2015
Q1
$108M Sell
1,205,900
-38,722
-3% -$3.43M 2.9% 1
2014
Q4
$103M Hold
1,244,622
2.7% 1
2014
Q3
$105M Buy
1,244,622
+223
+0% +$18K 2.81% 1
2014
Q2
$101M Hold
1,244,399
2.63% 1
2014
Q1
$94.8M Sell
1,244,399
-74,549
-6% -$5.43M 2.49% 2
2013
Q4
$95M Hold
1,318,948
2.42% 2
2013
Q3
$90.7M Hold
1,318,948
2.41% 1
2013
Q2
$83.6M Buy
+1,318,948
New +$85.8M 2.28% 2

Other funds holding NVS

Saturna Capital's NVS Position: Q1 2026 in Review

Saturna Capital reduced its Novartis (NVS) stake by 0.53% in Q1 2026, selling an estimated $254K and leaving 311,008 shares worth $47.5M. The position accounts for 0.67% of the portfolio, ranked #33.

Saturna Capital first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $108M in Q1 2015. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Saturna Capital held 311,008 shares of Novartis worth $47.5M as of Q1 2026.
  • Saturna Capital sold 1,654 Novartis shares in Q1 2026, an estimated $254K.
  • Novartis made up 0.67% of Saturna Capital's portfolio in Q1 2026, its #33 holding.
  • Saturna Capital first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Saturna Capital's Novartis position peaked at $108M in Q1 2015.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Saturna Capital's 13F filing for Q1 2026, filed 12 May 2026.